title: Bleeding associated with the management of acute coronary syndromes.
authors.affiliation: Department of Cardiology, King's College Hospital, London, UK.
authors.forename: Kalpa
authors.initials: K
authors.lastname: De Silva
authors.affiliation: Sussex Cardiac Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.|Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.
authors.forename: Aung
authors.initials: A
authors.lastname: Myat
authors.affiliation: Department of Cardiology, Heart and Lung Centre, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
authors.forename: James
authors.initials: J
authors.lastname: Cotton
authors.affiliation: Department of Medical Sciences and Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
authors.forename: Stefan
authors.initials: S
authors.lastname: James
authors.affiliation: Department of Cardiology, University of Leicester, Leicester, UK.|NIHR Leicester Cardiovascular Biomedical Research Centre, Leicester, UK.
authors.forename: Anthony
authors.initials: A
authors.lastname: Gershlick
authors.affiliation: Department of Cardiology, Columbia University Medical Center, New York Presbyterian Hospital, New York City, New York, USA.
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
mesh_terms: D054058:Acute Coronary Syndrome / Q000401:mortality / Q000628:therapy*; D000925:Anticoagulants / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors